Literature DB >> 29700955

Relationship between sodium, pentraxin-3 and aldosterone in inflammation and cardiovascular risk.

Decio Armanini1, Luciana Bordin2, Gabriella Donà2, Raffaele Pezzani1, Alessandra Andrisani3, Guido Ambrosini3, Chiara Sabbadin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29700955      PMCID： PMC8031008          DOI： 10.1111/jch.13298

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  19 in total

1.  Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate.

Authors:  Decio Armanini; Cristina Fiore; Donatella Pellati
Journal:  Hypertension       Date:  2007-08-20       Impact factor: 10.190

2.  The story of spironolactones from 1957 to now: from sodium balance to inflammation.

Authors:  Chiara Sabbadin; Lorenzo A Calò; Decio Armanini
Journal:  G Ital Nefrol       Date:  2016-02

3.  Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Chiara Bertello; Andrea Viola; Davide Tizzani; Andrea Iannaccone; Valentina Crudo; Jacopo Burrello; Alberto Milan; Franco Rabbia; Franco Veglio
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

4.  Production of the long pentraxin PTX3 in advanced atherosclerotic plaques.

Authors:  Michael S Rolph; Sabine Zimmer; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani; Göran K Hansson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

5.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.

Authors:  Lorenzo A Calò; Francesca Zaghetto; Elisa Pagnin; Paul A Davis; Paola De Mozzi; Paola Sartorato; Giuseppe Martire; Cristina Fiore; Decio Armanini
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

7.  Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.

Authors:  Mahmut Ilker Yilmaz; Jonas Axelsson; Alper Sonmez; Juan Jesus Carrero; Mutlu Saglam; Tayfun Eyileten; Kayser Caglar; Alper Kirkpantur; Turgay Celik; Yusuf Oguz; Abdulgaffar Vural; Mujdat Yenicesu; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

8.  The responses of the inflammatory marker, pentraxin 3, to dietary sodium and potassium interventions.

Authors:  Jia-Wen Hu; Yang Wang; Chao Chu; KeKe Wang; Yu Yan; Wenling Zheng; Qiong Ma; Jian-Jun Mu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-27       Impact factor: 3.738

9.  Hypothesis on a relationship between hyperaldosteronism, inflammation, somatic mutations, and autoimmunity.

Authors:  Decio Armanini; Alessandra Andrisani; Gabriella Donà; Luciana Bordin; Guido Ambrosini; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-20       Impact factor: 3.738

Review 10.  Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response.

Authors:  P Kunes; Z Holubcova; M Kolackova; J Krejsek
Journal:  Mediators Inflamm       Date:  2012-04-11       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.